Who
Tajinder S. Vohra
Please See Remarks
Company insider
Files Form 4 as: Please See Remarks, Revvity; Senior Vice President, Genpact.
In numbers
- Trades disclosed
- 158
- Buys
- 0
- Sells
- 34
- Bought
- $0
- Sold
- $8.9M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 15 Aug 2008
- Last trade
- 16 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 18 Sep 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $1.0M7,330 at $140.88 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $1.0M7,330 at $140.88 | filing |
| 17 Feb 2026filed 19 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $54K566 at $96.03 | filing |
| 17 Feb 2026filed 19 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $54K566 at $96.03 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $36K359 at $101.13 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —4,448 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code A | —12,722 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code A | —12,722 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $36K359 at $101.13 | filing |
| 4 Feb 2026filed 6 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code A | —4,448 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code M | $530K5,756 at $92.09 | filing |
| 2 Feb 2026filed 4 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $602K5,756 at $104.50 | filing |
| 2 Feb 2026filed 4 Feb 2026 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,756 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,756 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Code M | $530K5,756 at $92.09 | filing |
| 2 Feb 2026filed 4 Feb 2026 | RVTY RevvityLife-science tools | SEC FORM 4 Sold | $602K5,756 at $104.50 | filing |
| 15 Aug 2025filed 18 Aug 2025 | RVTY RevvityLife-science tools | SEC FORM 4 Code G | —12,183 at $0.00 | filing |
| 15 Aug 2025filed 18 Aug 2025 | RVTY RevvityLife-science tools | SEC FORM 4 Code G | —12,183 at $0.00 | filing |
| 4 Feb 2025filed 6 Feb 2025 | RVTY Revvityoption or derivative · Life-science tools | SEC FORM 4 Code A | —9,069 at $0.00 | filing |
| 4 Feb 2025filed 6 Feb 2025 | RVTY RevvityLife-science tools | SEC FORM 4 Code F | $38K307 at $123.69 | filing |
News
Codexis (NASDAQ:CDXS) and Revvity (NYSE:RVTY) Head-To-Head ComparisonRVTY · themarketsdaily.com · 19 Oct 2026Revvity (NYSE:RVTY) Stock Sale Disclosed by Rep. Gilbert Ray Cisneros, Jr.RVTY · dailypolitical.com · 14 Oct 2026Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Revvity Inc. (NYSE:RVTY)RVTY · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Tajinder S. Vohra; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.